Verbeke Evelyn, Bogaerts Annick, Nuyts Tinne, Crombag Neeltje, Luyten Jeroen
Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium.
Department of Development & Regeneration, Women & Child, REALIFE research group, Faculty of Medicine, KU Leuven, Leuven, Belgium.
Birth. 2022 Sep;49(3):364-402. doi: 10.1111/birt.12623. Epub 2022 Mar 24.
Mental health problems during and after pregnancy such as depression, anxiety, post-traumatic stress disorder (PTSD), or addiction are common and can have lifelong implications for both parents and offspring. This review investigates the cost-effectiveness of interventions tackling these problems, assesses the methodological quality of included studies, and indicates suggestions for further research.
Thirteen databases were searched for economic evaluations of interventions related to antenatal, perinatal, and postnatal mental health conditions, published between 2000 and September 2021, in high-income countries.
Thirty-nine studies met all inclusion criteria. Interventions considered were screening programs, pharmacological treatments, and various forms of psychosocial and psychological support. Six studies reported that the intervention was cost-saving. Eighteen were cost-effective and seven likely to be cost-effective. Only six studies included health outcomes for the child; one study considered paternal health. The time horizon for which costs and consequences were considered was for most evaluations limited to 1 year (n = 18) or 2 years (n = 11) postpartum.
Given the importance of the subject, a relatively low number of studies have investigated the cost-effectiveness of interventions tackling mental health problems during and after pregnancy. The scant evidence available suggests good overall value for money. Likely, cost-effectiveness is underestimated as costly long-term consequences on offspring are systematically excluded. No evidence was found for several frequently occurring conditions. Further research is required to obtain reliable, long-term effectiveness data and to address the methodological challenges related to measuring all relevant health outcomes for all parties affected.
孕期及产后的心理健康问题,如抑郁症、焦虑症、创伤后应激障碍(PTSD)或成瘾等很常见,可能会对父母和后代产生终身影响。本综述调查了解决这些问题的干预措施的成本效益,评估了纳入研究的方法学质量,并提出了进一步研究的建议。
检索了13个数据库,以查找2000年至2021年9月期间在高收入国家发表的与产前、围产期和产后心理健康状况相关干预措施的经济评估。
39项研究符合所有纳入标准。所考虑的干预措施包括筛查项目、药物治疗以及各种形式的心理社会和心理支持。6项研究报告称干预措施节省了成本。18项具有成本效益,7项可能具有成本效益。只有6项研究纳入了儿童的健康结果;1项研究考虑了父亲的健康。大多数评估中考虑成本和后果的时间范围仅限于产后1年(n = 18)或2年(n = 11)。
鉴于该主题的重要性,相对较少的研究调查了孕期及产后解决心理健康问题的干预措施的成本效益。现有证据不足表明总体性价比良好。可能由于系统地排除了对后代的长期高昂后果,成本效益被低估了。对于几种常见情况未发现证据。需要进一步研究以获得可靠的长期有效性数据,并应对与测量所有受影响方的所有相关健康结果相关的方法学挑战。